We are on a race against time
Every 3 seconds someone dies of sepsis. Many lives could be saved – every minute, every hour – with faster testing and appropriate treatment. QuickMIC saves precious time by providing reliable AST results in 2-4 hours, instead of days.
A global challenge
Sepsis, the body’s life-threatening response to infection, affects 50 million people every year of which about 20% do not survive today. With sepsis, time is critical: survival rates decrease dramatically with every hour of inappropriate antibiotic treatment. 1
Around 40% of sepsis patients do not receive appropriate initial treatment. QuickMIC provides results in record time so that patients can receive targeted antibiotic treatment faster than ever before.
Fighting antibiotic resistance
Sepsis is becoming harder to treat as antibiotics are losing their effectiveness due to increasing antibiotic resistance. Resistant infections are on the rise, already causing 35,000 deaths in Europe every year.
The World Health Organisation has stressed the urgent need for new rapid AST solutions to guide appropriate antibiotic treatment and reduce unnecessary antibiotic usage.
Large societal effects
Early detection and the right treatment administration positively impact the human and economic burden of sepsis, by saving more lives and reducing hospital costs due to shorter hospital stays.
Implementation of QuickMIC can result in a net saving of 4000€ per patient, which is ~30% of the hospital’s cost for a sepsis patient. 1,2
The value and benefits of QuickMIC
Learn more about QuickMIC
QuickMIC is an ultra-rapid system for antibiotic susceptibility testing. QuickMIC determines MIC values directly from positive blood cultures with incredible precision in just 2-4 hours.
References
- Gradientech Internal Health Economic Report, 2016.